Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Three Day BioPharma eMarketing Summit 2022: San Diego Mission Bay Resort, San Diego, California - June 7th-9th, 2022 - ResearchAndMarkets.com


The "2022 BioPharma eMarketing Summit" conference has been added to ResearchAndMarkets.com's offering.

Healthcare marketing has changed beyond all recognition. In a world of reduced access, how can marketers capitalize on this significant digital transformation and reinvent service value beyond the traditional model?

What are the avenues to engage HCPs and patients in the future? Whether working remotely and virtually engaging customers, or having to rethink your entire healthcare digital strategy, the 2022 BioPharma eMarketing Summit has the answers you need.

Now in its 7th year, we're back this June (in-person) for Pharma's one-of-a-kind digital marketing leadership Summit. 2022 is the BIGGEST program to date and will share multiple leading industry takeaways on digital strategy leadership, pandemic strategy pivoting, digital health disruption, B2B, B2C, content supply, big data/segmentation, AI/AR/VR, customer experience, patient activation, omni/multi-channel, social strategy, mobile engagement and much, much more. If you are involved in biopharma product or brand strategy, you won't want to miss this game-changing industry Summit!

Don't miss your chance to be part of the digital health movement and join 300+ leading pharma and biotech digital marketing pioneers willing to share their own digital strategies in this interactive, engaging "TED-style" Summit. Advance your ENTIRE TEAM with two years worth of new digital marketing strategies and expertise in just three days!

Inspiring Keynotes & 'TED-Style' Sessions

Over the years, BioPharma's awesome keynotes included leading marketing disruptors and innovators including Rand Fishkin and Ted Rubin. Our carefully curated 2022 speakers will inspire you and your team with their personal stories and visions for the future of marketing, sales, and business. In addition, BioPharma 2022 will feature multiple fun and interactive breakout sessions from some of the biggest names and brightest minds in sales and marketing.

Join the Digital Health Revolution

Join over 300+ senior marketing leadership pioneers looking to advance their marketing and engagement campaigns, and share their own personal stories on finding a successful long-term digital strategy in this unique, engaging "TED-style" Summit! BioPharma 2022 is designed BY industry, FOR industry, providing a fun, highly interactive forum for 100's of creative minds, thinkers, and digital marketers to share invaluable best practices, insights, tools, and techniques for making the most of your marketing and sales campaigns.

As well as the biopharma digital marketing strategies post COVID-19, we will be discussing:

Speakers

Neil Patel

New York Times Bestselling Author & Co-Founder

Neil Patel Digital

Bryan Kramer

Best-Selling Author, TED Speaker, Forbes Contributor & CEO

PureMatter

Lori Fraijo Raygoza

Vice President of eCommerce and Digital Marketing

Apria Healthcare

Craig Delarge

Former Head, Digital Acceleration, Takeda & Founder

Digital Mental Health Project

Bharat Tewarie

Executive Vice President and Chief Marketing Officer

UCB

Bryan Cohen

Director, Corporate Affairs, Internal Channels Lead

Pfizer Digital

Stefan Jensen

Chief Executive Officer, Partner

Motionstrand

Zach Duenow

Director Marketing Excellence, Brand Building & Creative Excellence

GlaxoSmithKline

Craig McGettigan

Head, Multichannel Engagement, US Business Operations & Support

Sanofi

Damon Harrell

Vice President Depression Marketing and New Products

Alkermes

Tarak Shah

Associate Director, Global Product Marketing Inflammation & Immunology

Celgene

Hans Kaspersetz

President, Chief Strategist, 2019 MM&M Top 100 Agency

Arteric

John Graham Jr.

Senior Manager, Global Employer Brand & Recruitment Marketing

Amgen

John Vieira

US, Head of Commercialization

Sol-Gel Technologies

Gaetan Akinrolabu

Associate Director, Paid Media and Social Media Strategy

Bristol-Myers Squibb

Terry Coutsolioutsos

Senior Vice President, Marketing, Sales Operations & Communications (MSC)

Siemens

For more information about this conference visit https://www.researchandmarkets.com/r/yzes93


These press releases may also interest you

at 20:50
Overture Launches Inner Circles: Redefining Private Attorney Referral Networks
Overture.law, the nation's leading attorney-to-attorney referral platform, launches their transformative new product, Inner Circles. This groundbreaking product empowers attorneys, law schools, bar associations, and affinity groups to build private...

at 20:09
Not Just 1, But 2: BASIS Charter Schools Celebrates a Pair of Students Named Presidential Scholars by the U.S. Department of Education
BASIS Charter Schools proudly announce that two of its exceptional students have been named 2024 U.S. Presidential Scholars by the U.S. Department of Education. Matteo N. Huish from BASIS Mesa and Sruti Peddi from BASIS Scottsdale have been...

at 20:00
Greenberg Traurigs Kemal Hawa to Moderate Panel at DICE East 2024
Kemal Hawa, co-chair of the Digital Infrastructure, Data Center and Cloud Computing Practice of global law firm Greenberg Traurig, LLP, will moderate a panel at DICE East 2024 May 22 in Reston, Virginia. Hawa, a member of the firm's Washington,...

at 19:45
WIO Taps Gracenote to Revolutionize Television Broadcast Reporting
WIO LLC, parent company of the global TV broadcast airings platform, WIOprotm, has announced a new strategic agreement with Gracenote, the global content data business unit of Nielsen, to address the longstanding challenge of accurately tracking and...

at 19:35
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

More news about Science and technology...


News published on and distributed by: